Risque thrombo-embolique de la thalidomide et des thérapeutiques anti-angiogéniques utilisées dans les cancers
- Other title
- Thromboembolic risk of thalidomide and antiangiogenic agents used to treat cancer (en)
- Author
- DROUET, Ludovic1
[1] Centre de conseil et de contrôle des traitements antithrombotiques, service d'angiohématologie, hôpital Lariboisière, 2, rue Ambroise-Paré, 75475 Paris, France - Source
STV. Sang thrombose vaisseaux. 2008, Vol 20, Num 5, pp 227-238, 12 p ; ref : 53 ref
- ISSN
- 0999-7385
- Scientific domain
- Cardiology, blood circulation, phlebology; Hematology
- Publisher
- John Libbey Eurotext, Montrouge
- Publication country
- France
- Document type
- Article
- Language
- French
- Author keyword
- VEGF angiogenèse anti-angiogénique cancer myélome thalidomide thrombose
- Keyword (fr)
- Angiogenèse Antiangiogénique Antibactérien Anticancéreux Antilépreux Article synthèse Complication Embolie Homme Hypnotique Myélome Pathologie de l'appareil circulatoire Psychotrope Risque Sédatif Thalidomide Thromboembolie Thrombose profonde Toxicité Traitement Tumeur maligne Anti-TNF-alpha Cancer Hémopathie maligne Immunoglobulinopathie Immunopathologie Pathologie des vaisseaux sanguins Pathologie des veines Syndrome lymphoprolifératif
- Keyword (en)
- Angiogenesis Antiangiogenic agent Antibacterial agent Antineoplastic agent Antileprous agent Review Complication Embolism Human Hypnotic Myeloma Cardiovascular disease Psychotropic Risk Sedative Thalidomide Thromboembolism Deep vein thrombosis Toxicity Treatment Malignant tumor Anti-Tumor Necrosis Factor-alpha Cancer Malignant hemopathy Immunoglobulinopathy Immunopathology Vascular disease Venous disease Lymphoproliferative syndrome
- Keyword (es)
- Angiogénesis Antiangiogenico Antibacteriano Anticanceroso Antileproso Artículo síntesis Complicación Embolia Hombre Hipnótico Mieloma Aparato circulatorio patología Psicotropo Riesgo Sedante Talidomida Tromboembolia Trombosis venosa profunda Toxicidad Tratamiento Tumor maligno Anti-TNF alfa Cáncer Hemopatía maligna Inmunoglobulinopatía Inmunopatología Vaso sanguíneo patología Vena patología Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B03 Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Cardiology. Circulatory system Immunopathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20452619
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:9:\"\u0000*\u0000jtitle\";s:29:\"STV. Sang thrombose vaisseaux\";s:9:\"\u0000*\u0000stitle\";s:23:\"STV, Sang thromb. vaiss\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"227\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0999-7385\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DROUET\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ludovic\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:9:\"\u0000*\u0000jtitle\";s:29:\"STV. Sang thrombose vaisseaux\";s:9:\"\u0000*\u0000stitle\";s:23:\"STV, Sang thromb. vaiss\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"227\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0999-7385\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DROUET\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ludovic\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:9:\"\u0000*\u0000jtitle\";s:29:\"STV. Sang thrombose vaisseaux\";s:9:\"\u0000*\u0000stitle\";s:23:\"STV, Sang thromb. vaiss\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"227\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0999-7385\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DROUET\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ludovic\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:9:\"\u0000*\u0000jtitle\";s:29:\"STV. Sang thrombose vaisseaux\";s:9:\"\u0000*\u0000stitle\";s:23:\"STV, Sang thromb. vaiss\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"227\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0999-7385\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DROUET\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ludovic\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:9:\"\u0000*\u0000jtitle\";s:29:\"STV. Sang thrombose vaisseaux\";s:9:\"\u0000*\u0000stitle\";s:23:\"STV, Sang thromb. vaiss\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"227\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0999-7385\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DROUET\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ludovic\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Risque thrombo-embolique de la thalidomide et des th\u00e9rapeutiques anti-angiog\u00e9niques utilis\u00e9es dans les cancers\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
